Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even...

Area of Science:

• Hematology
• Molecular Biology
• Genomics

Background:

• Primary plasma cell leukemia (pPCL) is an aggressive plasma cell disorder with poor prognosis.
• The 17p deletion is linked to poor outcomes in multiple myeloma (MM), but pPCL exhibits greater aggressiveness.
• Investigating isoform expression and RNA splicing may reveal underlying biological differences.

Purpose of the Study:

• To comprehensively explore isoform expression and RNA splicing events in pPCL and MM with 17p deletion.
• To identify novel biological differences between pPCL and MM using transcriptomic analysis.
• To elucidate the role of mRNA processing pathways in distinguishing pPCL from MM.

Main Methods:

• Transcriptomic studies were performed on newly diagnosed pPCL (n=9) and MM (n=10) samples, all with 17p deletion.
• Unsupervised cluster analysis was used to differentiate between pPCL and MM samples.
• Analysis focused on gene and isoform expression, including alternative splicing events.

Main Results:

• Unsupervised clustering clearly distinguished pPCL from MM samples.
• Transcriptome analysis identified 3584 deregulated genes and 20033 deregulated isoforms between pPCL and MM.
• Significant differences were observed in spliceosomal machinery components and alternative splicing events, including 2727 deregulated isoforms from non-differentially expressed genes.

Conclusions:

• Significant differences in relative isoform abundance exist between pPCL and MM, even with the 17p deletion.
• The mRNA processing pathway, particularly RNA splicing machinery, is a key mechanism underlying the biological distinctions between pPCL and MM.
• These findings offer insights into the molecular basis of pPCL aggressiveness.